Riskpilot← Back to searchSign inGet full accessSVEIN SALVESEN AS
ASActiveOrg 997441788Bærumsveien 225C, 1357 BekkestuaMedical specialists activities · NACE 8622Est. 20115 employees
Revenue 2024
NOK 12,4M
+3% vs 2023
EBITDA margin
64.1%
0% vs 2023
Equity ratio
81.4%
Financial strength
Net profit 2024
NOK 6,2M
+2% vs 2023
| Revenue | NOK 12,4M | +3% |
| EBITDA | NOK 7,9M | +0% |
| Net profit | NOK 6,2M | +2% |
| Total assets | NOK 50,7M | +4% |
| Equity | NOK 41,3M | +94% |
| Employees | 5 | — |
Legal name
SVEIN SALVESEN AS
Org number
997441788
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
8. oktober 2011
Share capital
NOK 300 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utføre helsetjenester, produksjon og salg, forskning, informasjon og konsulentvirksomhet, investering og utleie, samt deltagelse i annen virksomhet.
Address
Bærumsveien 225C, 1357 Bekkestua
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 988 | 10 217 | 12 341 | 12 040 | 12 359 |
| Staff expenses | −1 463 | −1 767 | −1 723 | −1 919 | −1 965 |
| EBITDA | 7 245 | 6 141 | 8 238 | 7 968 | 7 928 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 7 245 | 6 141 | 8 238 | 7 968 | 7 928 |
| Net financials | −323 | 4 195 | 1 749 | −181 | −86 |
| Profit before tax | 6 922 | 10 336 | 9 987 | 7 787 | 7 842 |
| Tax | 1 605 | 1 403 | 2 261 | 1 642 | 1 598 |
| Net profit | 5 317 | 8 934 | 7 726 | 6 145 | 6 244 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 46 477 | 55 315 | 48 323 | 48 988 | 50 715 |
| Equity | 32 414 | 23 984 | 22 809 | 21 255 | 41 299 |
| Long-term debt | 30 | 29 410 | 22 810 | 25 622 | 7 272 |
| Short-term debt | 14 034 | 1 922 | 2 704 | 2 111 | 2 144 |
| Total debt | 14 063 | 31 331 | 25 514 | 27 733 | 9 416 |
EBITDA margin
64.1%
This company
15.8%
Market median
+306% vs market
20202024
Equity ratio
81.4%
This company
38.2%
Market median
+113% vs market
20202024
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
20202024
Net profit margin
50.5%
This company
8.1%
Market median
+523% vs market
20202024
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Deputy Member | Deputy Member | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2011 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SVEIN SALVESEN AS 
ØYESENTERET ASBoard members of SVEIN SALVESEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Helge Salvesen | Deputy Member | 0 companies |
| Svein Osmund Salvesen | Chairman | 0 companies |